This week's must-know community updates, latest research & events
March 13, 2025 • Estimated Reading Time: 1 minute
New This Week
Exciting news! There is now a new section featuring clinical trials that are actively recruiting patients. This highly requested addition gives you direct access to cutting-edge research opportunities that could shape the future of treatment.
Stay informed about potentially life-changing studies and let us know what you think by replying to this email!
In a study by Ersal et al. (2025), researchers found that a significant number of hemophilia patients had low bone mineral density (BMD). The study involved 62 male patients, with a majority having severe hemophilia and being on factor prophylaxis. They discovered that 62.9% of the participants had lower than normal BMD, and 75% had a deficiency in vitamin D3. Notably, the parathyroid hormone (PTH)/calcium (Ca) ratio was identified as an independent risk factor for BMD, with a suggested optimal cut-off value of 6.57 for predicting low BMD.
The findings indicate that the PTH/Ca ratio could serve as a cost-effective and practical marker for assessing bone health in hemophilia patients. The study emphasizes the importance of routine screening for BMD and early intervention to prevent complications associated with low BMD in this population. Ersal et al. suggest that patients with a PTH/Ca ratio above 6.57 are approximately seven times more likely to have low BMD.
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
More Info 
Add to Calendar